Phase I-II first-in-human clinical trial of intraputamenal CDNF in Parkinson's disease: Exploratory fluid-based biomarker endpoints of the 12-month treatment periodH. Huttunen, S. Booms,H. Abdesselem,N. Majbour,O. El-Agnaf,I. Poggiolini,L. Parkkinen, A. Cryar, E. Sirka,J. Harris, M. Dove,M. Sjogren,M. Woolley,B. Murphy, P. Fielder,J. Baker, P. Skinner, M. Andreasson, G. Paul-Visse, R. Kivisaari, H. Bjartmarz,P. Almqvist,G. Lind,F. Scheperjans,H. Widner, P. SvenningssonMOVEMENT DISORDERS（2020）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
